Snap On Incorporated (SNA) Stock Price Today
Aura AI Summary
Key Stats
- $19.00BMarket Cap
- 367,027Volume
- IndustrialsSector
- $419.3152W High
- $328.6952W Low
- 40 DaysTypical Hold Time
- $18.63BEnterprise Value
- 2.66%Div Yield
- 0% Sell | 100% BuyTrading Activity
Track Snap On Incorporated (SNA) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Snap On Incorporated has traded between a low of $328.69 and a high of $419.31, highlighting its annual price range. Buy and sell Snap On Incorporated shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Snap On Incorporated
Snap-on Incorporated is a leading global innovator, manufacturer, and marketer of tools, equipment, diagnostics, repair information, and systems solutions for professional users. Its products are widely used in vehicle service and repair, as well as in other demanding industrial environments. The company is best known for its premium tool brand, often sold through a network of franchised mobile stores, and is a primary supplier to technicians in the transportation industry.
Most Recent News
VINCI wins €165M contract to build cooling plant for Iberian data center campus
VINCI's subsidiary Cobra IS secured a €165 million contract to construct a cooling plant for a major data center campus in the Iberian Peninsula. The project involves installing mechanical, electrical, and plumbing systems for 126 dry coolers, which ...

VINCI wins €165M contract for cooling system in large Iberian data center campus
VINCI's subsidiary Cobra IS secured a €165 million contract to build the cooling system for a massive data center campus in the Iberian Peninsula. The project includes installing mechanical, electrical, and plumbing equipment for 126 air cooling unit...

Basilea presents new data on antifungals fosmanogepix, isavuconazole, and antibiotic ceftobiprole at IDWeek 2026
Basilea Pharmaceutica announced new clinical and activity data for its antifungal drugs fosmanogepix and isavuconazole, as well as the antibiotic ceftobiprole, to be presented at IDWeek 2026 in Washington D.C. Highlights include pediatric data from f...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.